Abstract: Disclosed is an antibody that specifically binds CD70, or an antigen binding portion thereof. A nucleic acid molecule encoding the antibody or antigen binding portion thereof, an expression vector and a host cell comprising the nucleic acid molecule, a method for expressing the antibody or antigen binding portion thereof, and a method for treating a disease associated with CD70 signaling using the antibody or antigen binding portion thereof are also provided.
Type:
Grant
Filed:
March 3, 2022
Date of Patent:
March 28, 2023
Assignee:
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.
Inventors:
Wenzhi Tian, Song Li, Dianze Chen, Huiqin Guo